First Trust Advisors
NBSE

First Trust Advisors’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

First Trust Advisors’s Portfolio NBSE Stock Details NBSE Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
2021
Q2 		$350K Buy
2021
Q1 		$397K Buy
2020
Q4 		$344K Sell
2020
Q3 		$391K Buy